The PCL COVID19 Rapid FIA Test is an in vitro diagnostic medical device applying sandwich fluorescent immunoassay to qualitatively detect SARS CoV 2 antigen in human oropharyngeal /nasopharyngeal specimens and sputum specimens.
- 10 min Qualitative detection of SARS CoV 2 Antigens
- Human oropharyngeal swabs and deep sputum samples
- POCT Analyzer Provided
The PCL COVID19 Rapid FIA Test is manufactured in South Korea by PCL, Inc. and was approved by Health Canada on March 19, 2021.
Buy the PCL COVID19 Rapid FIA Test for Your WorkPlace
If your company or organization is interested in rapid testing solutions, contact us today for help procuring the PCL COVID19 Rapid FIA Test or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.